Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-04-30 @ 8:34 PM
Study NCT ID:
NCT00323869
Status:
COMPLETED
Last Update Posted:
2016-09-07
First Post:
2006-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
Sponsor:
Stanford University
Organization: